Colorectal Cancer Market
PUBLISHED: 2019 ID: SMRC18469
SHARE
SHARE

Colorectal Cancer Market

Colorectal Cancer - Global Market Outlook (2017-2026)

4.1 (79 reviews)
4.1 (79 reviews)
Published: 2019 ID: SMRC18469

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Colorectal Cancer Market is accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion by 2026 growing at a CAGR of 3.9% during the forecast period. Introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations are some of the factors fuelling the market growth. However, factors such as the reluctance toward colorectal cancer medications on the part of patients and a lack of awareness in many parts of the world will pose a threat to the growth of the overall market.

Colorectal cancer (CRC) is one of the “big four” tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together. CRC is believed to arise as a result of interactions between inherited and environmental factors. Despite improved prognosis of CRC patients in the last decade following advances in treatment options, survival rates still lag behind those of breast and prostate cancer patients.

Based on therapies & drugs, the increasing awareness for treating colorectal cancer by chemotherapy and immunotherapy propels the industry growth during the forecast period. By Geography, North America is a key region in the market and estimated to have a lucrative growth in terms of demand and revenue. This market is fueled by a number of factors, the primary one being greater prevalence of colorectal cancer.

Some of the key players profiled in the Colorectal Cancer market include Abbott Laboratories, Amgen Inc., Clinical Genomics, EDP Biotech, Epigenomics AG, Hoffmann-La Roche AG, Novigenix SA, Quest Diagnostics, Sanofi SA, Siemens Healthineers and VolitionRX.

Therapies & Drugs Covered:
• Chemo Therapy 
• Immuno Therapy 
• Radiation Therapy
• Surgery
• Others Therapies & Drugs

Testing & Diagnosis Covered:
• Immunochemistry
• Macroscopy
• Microscopy
• Staging
• Tumor Budding

Procedures Covered:
• Biopsy
• Colostomy
• Magnetic Resonance Imaging (MRI)
• Mammography
• Sigmoidoscopy 
 
Products Covered:
• Flow Cytometry
• In Situ Hybridization
• Microarrays
• Next-Generation Sequencing
• Targeted Therapy

Applications Covered:
• Hospitals and Clinics
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary        
          
2 Preface     
   
 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology      
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions      
          
3 Market Trend Analysis       
 3.1 Introduction       
 3.2 Drivers        
 3.3 Restraints       
 3.4 Opportunities       
 3.5 Threats        
 3.6 Product Analysis       
 3.7 Application Analysis      
 3.8 Emerging Markets       
 3.9 Futuristic Market Scenario      
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes      
 4.4 Threat of new entrants      
 4.5 Competitive rivalry       
          
5 Global Colorectal Cancer Market, By Therapies & Drugs    
 5.1 Introduction       
 5.2 Chemo Therapy       
  5.2.1 Alkylating Agent - Oxaliplatin (Eloxatin)    
  5.2.2 Antimetabolites      
   5.2.2.1 Capecitabine (Xeloda)    
   5.2.2.2 Fluorouracil (Adrucil)    
 5.3 Immuno Therapy       
  5.3.1 Biologic Response Modifiers     
  5.3.2 Colony-Stimulating Factors     
  5.3.3 Monoclonal Antibodies     
   5.3.3.1 Bevacizumab (Avastin)    
   5.3.3.2 Cetuximab (Erbitux)     
   5.3.3.3 Panitumumab (Vectibix)    
  5.3.4 Tumor Vaccines      
 5.4 Radiation Therapy       
 5.5 Surgery        
 5.6 Others Therapies & Drugs      
          
6 Global Colorectal Cancer Market, By Testing & Diagnosis    
 6.1 Introduction       
 6.2 Immunochemistry       
 6.3 Macroscopy       
 6.4 Microscopy       
 6.5 Staging        
 6.6 Tumor Budding       
          
7 Global Colorectal Cancer Market, By Procedure     
 7.1 Introduction       
 7.2 Biopsy        
 7.3 Colostomy       
 7.4 Magnetic Resonance Imaging (MRI)     
 7.5 Mammography       
 7.6 Sigmoidoscopy       
          
8 Global Colorectal Cancer Market, By Product 
   
 8.1 Introduction       
 8.2 Flow Cytometry       
 8.3 In Situ Hybridization      
 8.4 Microarrays       
 8.5 Next-Generation Sequencing      
 8.6 Targeted Therapy       
          
9 Global Colorectal Cancer Market, By Application     
 9.1 Introduction       
 9.2 Hospitals and Clinics      
 9.3 Other Applications       
          
10 Global Colorectal Cancer Market, By Geography     
 10.1 Introduction       
 10.2 North America       
  10.2.1 US       
  10.2.2 Canada       
  10.2.3 Mexico       
 10.3 Europe        
  10.3.1 Germany       
  10.3.2 UK       
  10.3.3 Italy       
  10.3.4 France       
  10.3.5 Spain       
  10.3.6 Rest of Europe      
 10.4 Asia Pacific       
  10.4.1 Japan       
  10.4.2 China       
  10.4.3 India       
  10.4.4 Australia       
  10.4.5 New Zealand      
  10.4.6 South Korea      
  10.4.7 Rest of Asia Pacific      
 10.5 South America       
  10.5.1 Argentina      
  10.5.2 Brazil       
  10.5.3 Chile       
  10.5.4 Rest of South America     
 10.6 Middle East & Africa      
  10.6.1 Saudi Arabia      
  10.6.2 UAE       
  10.6.3 Qatar       
  10.6.4 South Africa      
  10.6.5 Rest of Middle East & Africa     
          
11 Key Developments        
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 11.2 Acquisitions & Mergers      
 11.3 New Product Launch      
 11.4 Expansions       
 11.5 Other Key Strategies      
          
12 Company Profiling   
    
 12.1 Abbott Laboratories       
 12.2 Amgen Inc.       
 12.3 Clinical Genomics       
 12.4 EDP Biotech       
 12.5 Epigenomics AG       
 12.6 Hoffmann-La Roche AG      
 12.7 Novigenix SA       
 12.8 Quest Diagnostics       
 12.9 Sanofi SA        
 12.10 Siemens Healthineers      
 12.11 VolitionRX 

List of Tables         
1 Global Colorectal Cancer Market Outlook, By Region (2016-2026) ($MN)   
2 Global Colorectal Cancer Market Outlook, By Therapies & Drugs (2016-2026) ($MN)  
3 Global Colorectal Cancer Market Outlook, By Chemo Therapy (2016-2026) ($MN)  
4 Global Colorectal Cancer Market Outlook, By Alkylating Agent - Oxaliplatin (Eloxatin) (2016-2026) ($MN)
5 Global Colorectal Cancer Market Outlook, By Antimetabolites (2016-2026) ($MN)  
6 Global Colorectal Cancer Market Outlook, By Immuno Therapy (2016-2026) ($MN)  
7 Global Colorectal Cancer Market Outlook, By Biologic Response Modifiers (2016-2026) ($MN) 
8 Global Colorectal Cancer Market Outlook, By Colony-Stimulating Factors (2016-2026) ($MN) 
9 Global Colorectal Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN) 
10 Global Colorectal Cancer Market Outlook, By Tumor Vaccines (2016-2026) ($MN)  
11 Global Colorectal Cancer Market Outlook, By Radiation Therapy (2016-2026) ($MN)  
12 Global Colorectal Cancer Market Outlook, By Surgery (2016-2026) ($MN)   
13 Global Colorectal Cancer Market Outlook, By Others Therapies & Drugs (2016-2026) ($MN) 
14 Global Colorectal Cancer Market Outlook, By Testing & Diagnosis (2016-2026) ($MN) 
15 Global Colorectal Cancer Market Outlook, By Immunochemistry (2016-2026) ($MN)  
16 Global Colorectal Cancer Market Outlook, By Macroscopy (2016-2026) ($MN)  
17 Global Colorectal Cancer Market Outlook, By Microscopy (2016-2026) ($MN)  
18 Global Colorectal Cancer Market Outlook, By Staging (2016-2026) ($MN)   
19 Global Colorectal Cancer Market Outlook, By Tumor Budding (2016-2026) ($MN)  
20 Global Colorectal Cancer Market Outlook, By Procedure (2016-2026) ($MN)  
21 Global Colorectal Cancer Market Outlook, By Biopsy (2016-2026) ($MN)   
22 Global Colorectal Cancer Market Outlook, By Colostomy (2016-2026) ($MN)  
23 Global Colorectal Cancer Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
24 Global Colorectal Cancer Market Outlook, By Mammography (2016-2026) ($MN)  
25 Global Colorectal Cancer Market Outlook, By Sigmoidoscopy (2016-2026) ($MN)  
26 Global Colorectal Cancer Market Outlook, By Product (2016-2026) ($MN)   
27 Global Colorectal Cancer Market Outlook, By Flow Cytometry (2016-2026) ($MN)  
28 Global Colorectal Cancer Market Outlook, By In Situ Hybridization (2016-2026) ($MN) 
29 Global Colorectal Cancer Market Outlook, By Microarrays (2016-2026) ($MN)  
30 Global Colorectal Cancer Market Outlook, By Next-Generation Sequencing (2016-2026) ($MN)
31 Global Colorectal Cancer Market Outlook, By Targeted Therapy (2016-2026) ($MN)  
32 Global Colorectal Cancer Market Outlook, By Application (2016-2026) ($MN)  
33 Global Colorectal Cancer Market Outlook, By Hospitals and Clinics (2016-2026) ($MN) 
34 Global Colorectal Cancer Market Outlook, By Other Applications (2016-2026) ($MN) 
          
NOTE: The tables for North America, Europe, APAC, Middle East, Latin America, and Rest of the World Regions are also represented in the same manner as above.

 

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials